Bloggers

Channels

March 25, 2010 4:58 pm

Alliance with Syngene for novel cancer biologics diversifies Endo's pipeline
Gerson Lehrman Group
... acquisition added Vantas and Valstar to the company's marketed portfolio for the treatment of advanced prostate cancer and bladder cancer respectively. ...